🔗 Permalink

Inventor profile of:

Robert E. Reiter

City:

Los Angeles, California

Country:

United States

Published Applications:

40

Last publication date:

2024-01-25

Top Assignees for applications by Robert E. Reiter

The entities that hold a legal rights for patent applications filed by inventor Reiter Robert E.:

The Regents of the University of California 34 Oakland, CA United States
AGENSYS, INC. 8 Santa Monica, CA United States
CITY OF HOPE 3 Duarte, CA United States
The Regents of the University 1 Oakland, CA United States
Urogenesys, Inc. 1 Santa Monica, CA United States
The Regents of the University of California Office of Technology Transfer 1 Oakland, CA United States
The Regents of the University of Califorina 1 Oakland, CA United States

Recent patent applications by Reiter Robert E.

Robert E. Reiter from Los Angeles, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-25

US20240026025A1

Chemistry; metallurgy

HUMANIZED ANTI-N-CADHERIN ANTIBODIES AND USES THEREOF

#2 | 2023-06-15

US20230181772A1

Human necessities

ENGINEERED ANTI-PROSTATE STEM CELL ANTIGEN FUSION PROTEINS AND USES THEREOF

#3 | 2020-05-28

US20200165351A1

Chemistry; metallurgy

HUMANIZED ANTI-N-CADHERIN ANTIBODIES AND USES THEREOF

#4 | 2016-12-01

US20160347855A1

Chemistry; metallurgy

PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOF

#5 | 2015-08-27

US20150239983A1

Chemistry; metallurgy

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

#6 | 2015-06-25

US20150175706A1

Chemistry; metallurgy

Novel Antibodies Against Cancer Target Block Tumor Growth, Angiogenesis and Metastatis

#7 | 2014-12-11

US20140364591A1

Chemistry; metallurgy

PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOF

#8 | 2014-08-07

US20140220005A1

N-cadherin: target for cancer diagnosis and therapy

#9 | 2014-01-16

US20140017240A1

Human necessities

Fully Human Antibodies Against N-Cadherin

#10 | 2013-10-17

US20130274128A1

Chemistry; metallurgy

GENE EXPRESSION IN N-CADHERIN OVEREXPRESSING PROSTATE CANCERS AND THEIR CONTROLS

#11 | 2013-05-30

US20130137584A1

Chemistry; metallurgy

NOVEL DIAGNOSTIC AND THERAPEUTIC TARGETS ASSOCIATED WITH OR REGULATED BY N-CADHERIN EXPRESSION AND/OR EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) IN PROSTATE CANCER AND OTHER MALIGNANCIES

#12 | 2012-03-29

US20120077962A1

Chemistry; metallurgy

Humanized anti-prostate stem cell antigen monoclonal antibody

#13 | 2012-03-15

US20120063999A1

Chemistry; metallurgy

PSCA: prostate stem cell antigen and uses thereof

#14 | 2011-06-16

US20110142838A1

Chemistry; metallurgy

Antibodies against cancer target block tumor growth, angiogenesis and metastatis

#15 | 2011-04-14

US20110086029A1

Chemistry; metallurgy

NOVEL ANTIBODIES AGAINST CANCER TARGET BLOCK TUMOR GROWTH, ANGIOGENESIS AND METASTASIS

#16 | 2010-11-25

US20100297004A1

Chemistry; metallurgy

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

#17 | 2010-11-04

US20100278821A1

Chemistry; metallurgy

N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY

#18 | 2010-09-16

US20100233170A1

Human necessities

Fully human antibodies against N-cadherin

#19 | 2010-05-13

US20100119527A1

Human necessities

N-cadherin: target for cancer diagnosis and therapy

#20 | 2009-12-17

US20090311181A1

Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting

#21 | 2009-05-21

US20090130108A1

Chemistry; metallurgy

N-Cadherin and Ly6 E: Targets for Cancer Diagnosis and Therapy

#22 | 2009-04-23

US20090104631A1

Chemistry; metallurgy

PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia

#23 | 2008-12-25

US20080318254A9

Human necessities

PSCA antibodies and hybridomas producing them

#24 | 2008-12-25

US20080318253A9

Chemistry; metallurgy

Methods for inhibiting the growth of cancer cells expressing PSCA

#25 | 2008-08-26

US10446542

PSCA: prostate stem cell antigen and uses thereof

#26 | 2007-01-04

US20070006331A1

Human necessities

Mouse models of human prostate cancer

#27 | 2006-11-30

US20060269557A1

Chemistry; metallurgy

Humanized anti-prostate stem cell antigen monoclonal antibody

#28 | 2006-10-17

US10067705

Mouse models of human prostate cancer

#29 | 2006-05-30

US10022115

Mouse models of human prostate cancer progression

#30 | 2006-04-18

US9451214

E25A protein, methods for producing and use thereof

#31 | 2005-12-27

US10374381

Nucleic acids encoding prostate stem cell antigen

#32 | 2005-11-01

US10224720

Methods of detecting prostate stem cell antigen in cancer

#33 | 2005-10-18

US10062738

Mice models of human prostate cancer progression

#34 | 2005-09-27

US10066266

Methods of assessing the effect of a gene of interest on human prostate cancer progression

#35 | 2005-08-04

US20050169930A1

Chemistry; metallurgy

PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer

#36 | 2005-07-14

US20050152909A1

Chemistry; metallurgy

Mouse prostate stem cell antigen and uses thereof

#37 | 2005-04-19

US9855153

PSCA: prostate stem cell antigen and uses thereof

#38 | 2005-03-17

US20050059099A1

Chemistry; metallurgy

PSCA: prostate stem cell antigen and uses thereof

#39 | 2005-02-03

US20050026229A1

Human necessities

PSCA antibodies and hybridomas producing them

#40 | 2005-01-06

US20050003465A1

Chemistry; metallurgy

PSCA: prostate stem cell antigen and uses thereof

InventorID:

487913 ⎘